CIK 0001613103
- Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- Operating
- Phone
- +353 14381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-30 | Lerman Bradley E SVP General Counsel & Corp Sec | Exercise or conversion | +49,147 | $78.00 | $3.8M | 97,910 |
| 2021-09-30 | Lerman Bradley E SVP General Counsel & Corp Sec | Sale | −49,147 | $126.58 | $6.2M | 48,763 |
| 2021-09-30 | Lerman Bradley E SVP General Counsel & Corp Sec | Exercise or conversion · Stock Option (Right to Buy) | −49,147 | 0 | ||
| 2021-08-31 | Lerman Bradley E SVP General Counsel & Corp Sec | Exercise or conversion | +50,775 | $74.84 | $3.8M | 99,538 |
| 2021-08-31 | Lerman Bradley E SVP General Counsel & Corp Sec | Sale | −50,775 | $134.17 | $6.8M | 48,763 |
| 2021-08-31 | Lerman Bradley E SVP General Counsel & Corp Sec | Exercise or conversion · Stock Option (Right to Buy) | −50,775 | 0 | ||
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion | +21,129 | $38.81 | $820K | 54,458 |
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Sale | −21,129 | $134.08 | $2.8M | 33,329 |
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion | +2,577 | $38.81 | $100K | 35,906 |
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion | +4,713 | $38.20 | $180K | 40,619 |
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Sale | −7,290 | $134.09 | $978K | 33,329 |
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion · Stock Option (Right to Buy) | −21,129 | 0 | ||
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion · Stock Option (Right to Buy) | −2,577 | 0 | ||
| 2021-08-25 | Salmon Sean EVP & Pres Diabetes/Cardiovasc | Exercise or conversion · Stock Option (Right to Buy) | −4,713 | 0 | ||
| 2021-08-25 | Martha Geoffrey CEO | Exercise or conversion | +1,481 | $55.32 | $82K | 97,317 |
| 2021-08-25 | Martha Geoffrey CEO | Sale | −1,481 | $132.67 | $196K | 95,836 |
| 2021-08-25 | Martha Geoffrey CEO | Exercise or conversion | +10,100 | $62.76 | $634K | 105,936 |
| 2021-08-25 | Martha Geoffrey CEO | Sale | −10,100 | $132.67 | $1.3M | 95,836 |
| 2021-08-25 | Martha Geoffrey CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,481 | 0 | ||
| 2021-08-25 | Martha Geoffrey CEO | Exercise or conversion · Stock Option (Right to Buy) | −10,100 | 17,519 |
Page 28 of 49 · 966 trades